Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 9, Number 7—July 2003


Disease Surveillance and the Academic, Clinical, and Public Health Communities

Robert W. Pinner*Comments to Author , Catherine A. Rebmann*, Anne Schuchat*, and James M. Hughes*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 1

Surveillance and focus area for two core projects conducted at all Emerging Infections Program sitesa

Projects Type of surveillance Focus
Active Bacterial Core Surveillance Active, laboratory-based Invasive disease (isolated from a normally sterile site such as blood or cerebrospinal fluid) caused by group A streptococcus, group B streptococcus, Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae
FoodNet/Foodborne Disease Active Surveillance Active, laboratory-based Disease (first isolation from a person) caused by Campylobacter, Listeria, Salmonella, Shigella, Yersinia, Vibrio, Shiga toxin–producing Escherichia coli, including O157:H7, Cryptosporidium, and Cyclospora

aIntended to generate reliable estimates of the incidence of certain infections and provide the foundation for a variety of epidemiologic studies to explore risk factors, disease spectrum, and prevention strategies.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO